Skip to main content
OpenTrials
Completed

NCT Number: NCT00885300

Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients

The purpose of this study is to investigate whether cloxacillin lock is effective in prevention of double lumen infection.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Double Lumen Infection Hemodialysis

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Shiraz University Hemodialysis Center

Shiraz, Fars, o98-711, Iran

About this study

Double lumen infection is one of the causes of morbidity and mortality in hemodialysis patients. Many strategies used to prevent it and one of them is antibiotic lock. Thus we select chronic hemodialysis patients and divided them into 2 groups. One group received cloxacillin and heparin as catheter lock and the second group received only heparin lock.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • hemodialysis for 3 months
  • at least 2 time dialysis/week

Exclusion criteria

  • active infection
  • acute renal failure

Treatment and study plan

Cloxacillin

Drug

cloxacillin 100mg/ml as catheter lock at the end of hemodialysis

Heparin

Drug

heparin 1000iu/ml as catheter lock at the end of hemodialysis

Primary outcomes

  1. catheter infection

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Shiraz University of Medical Sciences

Other

Registry information

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Apr 21, 2009
Registry last updated
Apr 21, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.